Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neoplasms 3Neoplasm Metastasis 3Glioblastoma 3Central Nervous System Neoplasms 3Sarcoma 2Rectal Neoplasms 2Melanoma 2Gliosarcoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Solitary Fibrous Tumor, Pleural 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1

Interventions

Ifosfamide 7Doxorubicin 6Radiotherapy 5Filgrastim 3Chemotherapy, Adjuvant 3Vincristine 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2vatalanib 1soblidotin 1romidepsin 1perifosine 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1Watchful Waiting 1Trabectedin 1Sunitinib 1Sorafenib 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Observation 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemangiopericytoma, Malignant × vatalanib × Clear all
NCT00348790 2018-10-26

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Northwestern University

Phase 2 Completed
25 enrolled 10 charts
CNSSarcoma

Hemangiopericytoma, Malignant, Brain Neoplasms, Meningioma, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡